6 Meridian’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-6,757	Closed	-$873K	–	476
2018 Q2	$873K	Sell	6,757 -67	-1%	-$8.66K	0.09%	124
2018 Q1	$703K	Buy	+6,824	New	+$703K	0.08%	130